Is immunosuppressive therapy the anchor treatment to achieve remission in systemic sclerosis?
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is immunosuppressive therapy the anchor treatment to achieve remission in systemic sclerosis?
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume 53, Issue 6, Pages 975-987
Publisher
Oxford University Press (OUP)
Online
2013-11-02
DOI
10.1093/rheumatology/ket312
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LB0002 The astis trial: Autologous stem cell transplantation versus IV pulse cyclophosphamide in poor prognosis systemic sclerosis, first results
- (2014) J.M. van Laar et al. ANNALS OF THE RHEUMATIC DISEASES
- Enteric-coated mycophenolate sodium for progressive systemic sclerosis—a prospective open-label study with CT histography for monitoring of pulmonary fibrosis
- (2013) Joerg C. Henes et al. CLINICAL RHEUMATOLOGY
- Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study
- (2012) Muriel Elhai et al. ANNALS OF THE RHEUMATIC DISEASES
- Treatment of Systemic Sclerosis Complications: What to Use When First-Line Treatment Fails—A Consensus of Systemic Sclerosis Experts
- (2012) Kyle M. Walker et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis
- (2011) E. N. Le et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of mycophenolate sodium in scleroderma-related interstitial lung disease
- (2011) Carmen Pilar Simeón-Aznar et al. CLINICAL RHEUMATOLOGY
- Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies
- (2011) M. Elhai et al. RHEUMATOLOGY
- The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label study
- (2010) M. O. Becker et al. ANNALS OF THE RHEUMATIC DISEASES
- Evidence-based management of rapidly progressing systemic sclerosis
- (2010) Dinesh Khanna et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
- (2010) Athanasios Koutroumpas et al. CLINICAL RHEUMATOLOGY
- Immunotherapy of systemic sclerosis
- (2010) Rebecca Manno et al. Immunotherapy
- Biologic Therapy for Systemic Sclerosis: A Systematic Review
- (2010) V. PHUMETHUM et al. JOURNAL OF RHEUMATOLOGY
- The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
- (2010) Y. Shima et al. RHEUMATOLOGY
- A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass
- (2010) Monica Ibañez et al. ARTHRITIS RESEARCH & THERAPY
- EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)
- (2009) O Kowal-Bielecka et al. ANNALS OF THE RHEUMATIC DISEASES
- Rapamycin versus methotrexate in early diffuse systemic sclerosis: Results from a randomized, single-blind pilot study
- (2009) Tien-I Karleen Su et al. ARTHRITIS AND RHEUMATISM
- B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis
- (2009) Robert Lafyatis et al. ARTHRITIS AND RHEUMATISM
- Observational Study of Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis
- (2009) A. L. HERRICK et al. JOURNAL OF RHEUMATOLOGY
- A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
- (2009) C. T. Derk et al. RHEUMATOLOGY
- Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
- (2009) Dimitrios Daoussis et al. RHEUMATOLOGY
- Interstitial Lung Disease in Systemic Sclerosis
- (2008) Nicole S. L. Goh et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis
- (2008) C P Denton et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study
- (2008) V Smith et al. ANNALS OF THE RHEUMATIC DISEASES
- The safety of mycophenolate mofetil in pregnancy
- (2008) Cecilia N Pisoni et al. Expert Opinion On Drug Safety
- Shifting Our Thinking About Uncommon Disease Trials: The Case of Methotrexate in Scleroderma
- (2008) Sindhu R. Johnson et al. JOURNAL OF RHEUMATOLOGY
- Stem cell transplantation for rheumatic autoimmune diseases
- (2008) Thomas Hügle et al. ARTHRITIS RESEARCH & THERAPY
- Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies
- (2008) Carlotta Nannini et al. ARTHRITIS RESEARCH & THERAPY
- High-dose cyclophosphamide without stem cell rescue in scleroderma
- (2007) C V Tehlirian et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of Mycophenolate Mofetil on Pulmonary Function in Scleroderma-Associated Interstitial Lung Disease
- (2007) Anthony J. Gerbino et al. CHEST
- Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease
- (2007) Ana C. Zamora et al. RESPIRATORY MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More